Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Rheumatol. 2016 May 1;43(8):1581–1588. doi: 10.3899/jrheum.151419

Table 4. Predictors of ED hospital charges among patients presenting to ER with gout using linear regression.

Univariate Multivariable-adjusted

B-estimate* (95% CI) P-value B-estimate* (95% CI) P-value

Age
 <50 Ref Ref
 50- <65 135.32 (91.77, 178.87) <0.0001 34.96 (-7.66, 77.58) 0.1077
 65- <80 432.69 (373.31, 492.06) <0.0001 194.44 (126.28, 262.59) <0.0001
 ≥80 629.29 (529.00, 729.59) <0.0001 297.27 (190.66, 403.88) <0.0001
Gender
 Female (ref) Ref Ref
 Male -189.66 (-233.35, -145.97) <0.0001 -47.91 (-93.72, -2.10) 0.0404
Median household annual income
 Lowest quartile (< $38,999) Ref Ref
 2nd quartile ($39,000 to $47,999) 15.52 (-59.21, 90.25) 0.6836 -10.64 (-82.12, 60.85) 0.7703
 3rd quartile ($48,000 to $62,999) 161.60 (47.12, 276.08) 0.0057 61.75 (-38.56,162.06) 0.2272
 Highest quartile ($63,000 or more) 326.75 (175.69, 477.82) <0.0001 163.24 (20.22, 306.26) 0.0253
Primary payer
 Medicare (ref) Ref Ref
 Medicaid -287.55 (-355.54, -219.56) <0.0001 -38.93 (-111.09, 33.24) 0.29
 Private insurance -288.14 (-353.26, -223.02) <0.0001 -36.32 (-101.06, 28.43) 0.2712
 Self-pay -407.62 (-466.61, -348.63) <0.0001 -64.21 (-135.71,7.29) 0.0783
 Uninsured/no charge 41.58 (-231.89, 315.06) 0.7654 331.83 (48.95, 614.72) 0.0216
 Other -445.00 (-542.37, -347.64) <0.0001 -182.50 (-284.05, -80.95) 0.0004
Patient residence
 Micropolitan/not metro Ref Ref
 Metro (large or small) 399.80 (302.92, 496.69) <0.0001 297.62 (195.46, 399.79) <0.0001
Hospital Region
 Northeast Ref Ref
 Midwest -152.64 (-359.63, 54.35) 0.1481 -67.25 (-266.14, 131.65) 0.507
 South -164.93 (-358.25, 28.40) 0.0944 -25.11 (-218.92, 168.69) 0.7993
 West 207.08 (16.56, 397.60) 0.0332 456.24 (263.16, 649.31) <0.0001
Teaching status of hospital
 Metropolitan non -teaching or non-metro Ref Ref
 Metropolitan teaching 265.81 (130.46, 401.15) 0.0001 120.67 (-25.82, 267.16) 0.1063
Comorbidities
 CHD (ref: no) 612.59 (490.46, 734.73) <0.0001 187.85 (64.28, 311.42) 0.0029
 Hyperlipidemia (ref: no) 476.23 (383.64, 568.82) <0.0001 79.03 (-8.63, 166.70) 0.0771
 Renal failure (ref: no) 1038.97 (871.53, 1206.40) <0.0001 646.76 (484.36, 809.16) <0.0001
 Heart failure (ref: no) 602.79 (480.09, 725.49) <0.0001 116.96 (2.97, 230.95) 0.0443
 Hypertension (ref: no) 380.15 (320.33, 439.97) <0.0001 121.65 (65.82,177.48) <0.0001
 Diabetes (ref: no) 466.90 (384.78, 549.03) <0.0001 196.34 (120.43, 272.25) <0.0001
 COPD (ref: no) 571.87 (414.57, 729.16) <0.0001 164.54 (10.59, 318.50) 0.0362
 Osteoarthritis (ref: no) 901.13 (723.85, 1078.41) <0.0001 551.31 (384.74, 717.89) <0.0001

CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease.

Significant beta estimates and odds ratios are in bold.